Related Experiment Videos
[Thromboembolic complications in laparoscopic surgery and their prophylaxis]
Klinichna Khirurhiia
|September 5, 2003
Summary
Low-molecular heparin fraxiparin effectively prevents thromboembolic complications in patients undergoing laparoscopic surgery. Prophylactic use significantly reduced the occurrence of deep vein thrombosis and pulmonary embolism, demonstrating its clinical value.
Area of Science:
- Medical research
- Surgical outcomes
- Thromboembolic disease
Context:
- Laparoscopic surgery is a common minimally invasive procedure.
- Thromboembolic complications pose a risk in surgical patients.
- Perioperative prophylaxis is crucial for patient safety.
Purpose:
- To evaluate the frequency of thromboembolic complications after laparoscopic intervention.
- To assess the efficacy of prophylactic perioperative low-molecular heparin fraxiparin.
- To determine the overall incidence of venous thromboembolism in this patient cohort.
Summary:
- A study of 8230 patients undergoing laparoscopic procedures investigated thromboembolic complication rates.
- Prophylactic administration of low-molecular heparin fraxiparin was employed.
- Deep vein thrombosis occurred in 0.073% and pulmonary artery embolism in 0.037% of patients, totaling 0.11%.
Impact:
- Low-molecular heparin fraxiparin demonstrates high efficacy in preventing major thromboembolic events.
- The findings support the routine use of this anticoagulant for perioperative thromboembolic prophylaxis.
- Minimizing VTE risk enhances patient safety and improves surgical outcomes.